James T. Limberis

N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties

Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 249 citations · Full text

The Canine Purkinje Fiber: An In Vitro Model System for Acquired Long QT Syndrome and Drug-Induced Arrhythmogenesis

Gary A. Gintant, James T. Limberis, Jeff S. McDermott et al. · Journal of Cardiovascular Pharmacology · 2001 · 159 citations

Cardiac Muscle, Heart Failure, Pathology +16

Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.

Jonathan C. Makielski, James T. Limberis, Steven Y. Chang et al. · Molecular Pharmacology · 1996 · 66 citations

Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties

Brian Dyck, Bryan J. Branstetter, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2017 · 54 citations · Full text

Optimization of Chromone-2-carboxamide Melanin Concentrating Hormone Receptor 1 Antagonists:  Assessment of Potency, Efficacy, and Cardiovascular Safety

J.A. Lynch, Jennifer C. Freeman, Andrew S. Judd et al. · Journal of Medicinal Chemistry · 2006 · 48 citations · Full text

Metabolic Syndrome, Medicinal Chemistry, Distinct Series +14